Citadel Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.76M | Buy |
|
|||||
|
2025
Q1 | – | Hold |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $2.38M | Sell |
|
|||||
|
2024
Q2 | $3.86M | Sell |
|
|||||
|
2024
Q1 | $3.62M | Buy |
|
|||||
|
2023
Q4 | $700K | Sell |
|
|||||
|
2023
Q3 | $1.92M | Buy |
|
|||||
|
2023
Q2 | $206K | Sell |
|
|||||
|
2023
Q1 | $5.36M | Sell |
|
|||||
|
2022
Q4 | $10.2M | Buy |
|
|||||
|
2022
Q3 | $1.89M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $209K | Sell |
|
|||||
|
2021
Q4 | $497K | Sell |
|
|||||
|
2021
Q3 | $1.89M | Buy |
|
|||||
|
2021
Q2 | $952K | Sell |
|
|||||
|
2021
Q1 | $1.34M | Sell |
|
|||||
|
2020
Q4 | $9.75M | Sell |
|
|||||
|
2020
Q3 | $21.6M | Buy |
|
|||||
|
2020
Q2 | $9.39M | Sell |
|
|||||
|
2020
Q1 | $13.8M | Buy |
|
|||||
|
2019
Q4 | $12.8M | Sell |
|
|||||
|
2019
Q3 | $12.3M | Buy |
|
|||||
|
2019
Q2 | $8.46M | Sell |
|
|||||
|
2019
Q1 | $13.3M | Buy |
|
|||||
|
2018
Q4 | $7.69M | Buy |
|
|||||
|
2018
Q3 | $706K | Sell |
|
|||||
|
2018
Q2 | $2.39M | Buy |
|
|||||
|
2018
Q1 | $234K | Sell |
|
|||||
|
2017
Q4 | $334K | Sell |
|
|||||
|
2017
Q3 | $515K | Buy |
|
|||||
|
2017
Q2 | – | Hold |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $210K | Sell |
|
|||||
|
2016
Q3 | $382K | Buy |
|
|||||
|
2016
Q2 | – | Hold |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $207K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $277K | Sell |
|
|||||
|
2015
Q1 | $271K | Sell |
|
|||||
|
2014
Q4 | $244K | Buy |
|
|||||
|
2014
Q3 | $141K | Buy |
|
|||||
|
2014
Q2 | $174K | Sell |
|
|||||
|
2014
Q1 | $2.12M | Buy |
|
|||||
|
2013
Q4 | $247K | Sell |
|
|||||
|
2013
Q3 | $1.7M | Buy |
|